Multiple sclerosis treatment

Details Multiple sclerosis treatment Multiple sclerosis treatment

1996-02-13

1998-02-10

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

9,10-seco- cyclopentanohydrophenanthrene ring system doai

A61K 3159

Patent

active

057169462

ABSTRACT:
A method of treating the multiple sclerosis symptoms of a multiple sclerosis patient is disclosed comprising administering to a multiple sclerosis patient an amount of a vitamin D compound effective to reduce symptoms and to enable an observation of a reduction in symptoms.

REFERENCES:
patent: 4279826 (1981-07-01), DeLuca et al.
patent: 4307025 (1981-12-01), DeLuca et al.
patent: 4448721 (1984-05-01), DeLuca et al.
patent: 4500460 (1985-02-01), DeLuca et al.
patent: 4502991 (1985-03-01), DeLuca et al.
patent: 4505906 (1985-03-01), DeLuca et al.
patent: 4552698 (1985-11-01), DeLuca et al.
patent: 4588528 (1986-05-01), DeLuca et al.
patent: 4594192 (1986-06-01), DeLuca et al.
patent: 4619920 (1986-10-01), DeLuca et al.
patent: 4769181 (1988-09-01), DeLuca et al.
patent: 4973584 (1990-11-01), DeLuca et al.
patent: 5030772 (1991-07-01), DeLuca et al.
patent: 5036061 (1991-07-01), DeLuca et al.
patent: 5237110 (1993-08-01), DeLuca et al.
patent: 5260199 (1993-11-01), DeLuca et al.
patent: 5260290 (1993-11-01), DeLuca et al.
patent: 5328903 (1994-07-01), Ishii et al.
patent: 5371249 (1994-12-01), DeLuca et al.
patent: 5373004 (1994-12-01), DeLuca et al.
patent: 5380720 (1995-01-01), DeLuca et al.
patent: 5395830 (1995-03-01), DeLuca et al.
patent: 5397775 (1995-03-01), DeLuca et al.
patent: 5414098 (1995-05-01), DeLuca et al.
Muller et al., Autoimmunity, (1992) 14(1) 37-43.
D. Branisteanu, et al., "Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1.alpha.25-(OH).sub.2 D.sub.3," J. Neuroimmun. 61(199):151-160, 1995.
M. Cantorna, et al., "1,25-Dihydroxyvitamin D.sub.3 reversibly blocks the progression of relapsing encephalomyelits, a model of multiple sclerosis," Proc. Natl. Acad. Sci. USA 93:7861-7864, 1996.
J. Lemire, et al., "1,25-Dihydroxyvitamin D.sub.3 Prevents the In Vivo Induction of Murine Experimental Autoimmune Encephalomyelitis," J. Clin. Invest. 87:1103-1107, 1991.
S. Nataf, et al., "1,25-Dihydroxyvitamin D.sub.3 Exerts Regional Effects in the Central Nervous System during Experimental Allergic Encephalomyelitis," J. Neuropath. Exp. Neurol. 55(8):904-914, 1996.
M. Saporito, et al., "Chronic 1,25-dihydroxyvitamin D.sub.3 -mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain," Brain Res. 633:189-196, 1994.
D. Tweedie, "Vitamin Treatment of Hemiplegia," Med. J. Malaysia 33 (2):193-194, 1978.
Ebers, George C., et al., "A Population-Based Study of Multiple Sclerosis in Twins," N. Engl. J. Med., 1986; 315:1638-42.
Ebers, George C., et al., "A full genome search in multiple sclerosis," Nature Genet., 1996, 13:472-76.
Haines, J.L., et al. (The Multiple Sclerosis Genetics Group), "A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex," Nature Genet., 1996, 13:469-71.
Sawcer, Stephen, et al., "A genome screen in mutliple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22," Nature Genet., 1996, 13:464-68.
Bhalla, Ashok K., et al., "1,25-Dihydroxyvitamin D.sub.3 Inhibits Antigen-Induced T Cell Activation," J. Immunol., 1984, 133:1748-54.
Lacey, David L., et al., "Vitamin D Affects Proliferation of a Murine T Helper Cell Clone," J. Immunol., 1987, 138:1680-86.
Lemire, Jacques M., et al., "1.alpha.,25-Dihydroxyvitamin D.sub.3 Supresses Proliferation and Immunoglobulin Production by Normal Human Peripheral Blood Mononuclear Cells," J. Clin. Invest., 1984, 74:657-61.
Rigby, William F.C., et al., "Inhibition of T Lymphocyte Mitogenesis by 1,25-Dihydroxyvitamin D.sub.3 (Calcitriol)," J. Clin. Invest., 1984, 74:1451-55.
J.-F. Bach, "Immunosuppressive therapy of autoimmune diseases," Immun. Today 14(6):322-326, 1993.
S. Brocke, et al., "Infection and multiple sclerosis: a possible role for superantigens?" Trends in Microbiol. 2(7):250-254, 1994.
S. D. Miller and W. J. Karpus, "The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases," Immun. Today 15(8):356-361, 1994.
R. A. Rudick and D. E. Goodkin, "Measuring Impairment and Disability," Treatment of Multiple Sclerosis: Trial Design, Results and Future Perspectives, Springer-Verlag, London, pp. 48-53, 1992.
L. Steinman, "Escape from `Horror Autotoxicus`: Pathogenesis and Treatment of Autoimmune Disease," Cell 80:7-10, 1995.

Affiliated with

Also associated with

Rating

Multiple sclerosis treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multiple sclerosis treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiple sclerosis treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2077484